Alumis

Last updated: November 16, 2025
CEO - Martin Babler
CEO - Martin Babler
Country: USA | Funding: $569M (+)
Founded: 2021

Website: https://www.alumis.com/

Alumis is a precision medicines company that is transforming the lives of patients living with immune-mediated diseases using a precision approach to develop oral therapies.




Competitors